Supriya Pharmaceuticals (Delisted) financials and balance sheet

BSE: 524784

Delisted on 23 Aug 2017.

1 year at a glance

Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to September.

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
  • Loss

Operating and net margin, per cent

  • Operating margin
  • Net margin

Results for the year to Sep 2007

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue0.2
  2. Operating expenses−0.2
  3. Operating profit−0.1
  4. Depreciation−0.2
  5. Other income+0.2
  6. Finance costs0.0
  7. Profit before tax−0.1
  8. Net profit−0.1

Profit and loss

Standalone, ₹ crore, years to September.Supriya Pharmaceuticals quarterly results

₹ croreSep 2007
Revenue from operations0.16
Operating expenses0.23
Operating profit before depreciation−0.07
Operating margin−44.9%
Depreciation and amortisation0.18
Operating profit after depreciation−0.25
Other income0.16
Finance costs0.00
Profit before tax−0.07
Net profit−0.07
Net margin−46.2%